Intravacc Awarded US$14.6 Million NIH/NIAID Contract to Develop Intranasal Gonorrhea Vaccine - PR Newswire

/PRNewswire/ -- Intravacc, a world leader in translational research and development of preventive and therapeutic vaccines, today announced that it has been...

• Gonorrhea is on the WHO high-priority list of antimicrobial resistant bacteria
• World's first intranasal prophylactic gonorrhea vaccine candidate
• Mucosal vaccine platforms prov… [+5250 chars] Read More
  
  
  
  

  Other Stories in Health

  • Dosa saree, Idli shirt and a pani puri watch? AI turns desi food into fashion
  • Where and why men die younger: global data breaks it down
  • 8 Best Foldable Rowing Machines, According to Editors and Certified Trainers
  • Strawberry Lemon Cream Crepes {Grain-Free Options Included}
  • What predicts belief in the afterlife? A massive global study has answers
  • Getting active in midlife may boost brain resilience to Alzheimer’s
  • May 2025 Cooking Challenge
  • May 2025 Cooking Challenge
  • TDP-43 dysfunction in brain blood vessels may drive Alzheimer's and ALS progression